89 related articles for article (PubMed ID: 1990673)
1. Temporary anti-CD-25 treatment results in tolerance development in syngeneically grafted autoimmune diabetic recipients.
Hahn HJ; Kuttler B; Dunger A; Lucke S; Volk HD; Diamantstein T
Transplant Proc; 1991 Feb; 23(1 Pt 1):741-2. PubMed ID: 1990673
[No Abstract] [Full Text] [Related]
2. Effect of temporary IL-2 receptor MAB therapy on islet allograft in autoimmune diabetes.
Hahn HJ; Kuttler B; Lucke S; Dunger A; Besch W; Volk HD; Diamankstein T
Transplant Proc; 1989 Feb; 21(1 Pt 3):2711-3. PubMed ID: 2495678
[No Abstract] [Full Text] [Related]
3. Interleukin 2 receptor-targeted therapy in islet transplantation research.
Hahn HJ; Kuttler B; Volk HD; Lucke S; Diamantstein T
Horm Metab Res Suppl; 1990; 25():177-80. PubMed ID: 2088963
[No Abstract] [Full Text] [Related]
4. Effect of anti-interleukin-2 receptor antibody treatment on recurrent autoimmune insulitis in the BB rat.
Woehrle M; Pullmann J; Stuenkel KG; Bretzel RG; Federlin K
Transplant Proc; 1994 Apr; 26(2):734-5. PubMed ID: 8171631
[No Abstract] [Full Text] [Related]
5. Successful islet transplantation in BB rats without chronic immunosuppression.
Chabot JA; Lau H; Reemtsma K; Hardy MA
Transplant Proc; 1987 Feb; 19(1 Pt 2):974-5. PubMed ID: 3152652
[No Abstract] [Full Text] [Related]
6. Temporary anti-CD25/CsA therapy induces a CD4+ T-cell-mediated tolerance in BB/OK rats.
Kuttler B; Kauert C; Wanka H; Diamantstein T; Hahn HJ
J Autoimmun; 1996 Jun; 9(3):321-9. PubMed ID: 8816967
[TBL] [Abstract][Full Text] [Related]
7. Tolerance to islet xenografts induced by dual manipulation of antigen presentation and co-stimulation.
Markees TG; Appel MC; Noelle RJ; Mordes JP; Greiner DL; Rossini AA
Transplant Proc; 1996 Apr; 28(2):814-5. PubMed ID: 8623413
[No Abstract] [Full Text] [Related]
8. Beta cell destruction of pancreatic islets transplanted into diabetic BB/OK rats may be reflected by increased antibody-mediated anti-islet cytotoxicity.
Schröder D; Wanka H; Hehmke B; Klöting I; Köhler E; Knospe S; Schmidt S
Diabetes Res; 1990 Sep; 15(1):27-32. PubMed ID: 2132197
[TBL] [Abstract][Full Text] [Related]
9. Prevention of islet graft destruction in diabetic mice and rats by temporary anti-IL-2 receptor therapy: comparison of different strategies.
Kuttler B; Mathieu C; Bulfone-Paus S; Bouillon R; Diamantstein T; Hahn HJ
Transplant Proc; 1998 Dec; 30(8):4140-2. PubMed ID: 9865327
[No Abstract] [Full Text] [Related]
10. Interleukin 2 receptor targeted immunotherapy in the prevention of autoimmune beta-cell destruction as observed in diabetic BB/OK rats grafted with BB/OK rat islets.
Hahn HJ; Kauert C; Dunger A; Kuttler B; Diamantstein T
Autoimmunity; 1989; 5(1-2):139-42. PubMed ID: 2519014
[No Abstract] [Full Text] [Related]
11. Low-dose anti-CD3 therapy provides long-term graft survival in a Lewis rat to C57BL/6 xeno-islet transplantation model.
Jeyarajah DR; Schmeisser FS; Josephson MA; Sohn DG; Thistlethwaite JR
Transplant Proc; 1994 Apr; 26(2):771-3. PubMed ID: 8171656
[No Abstract] [Full Text] [Related]
12. Prolongation of islet allografts by pretreatment with intrathymic UV-B donor spleen cells.
Jin MX; Chowdhury NC; James T; Engelstad K; Hardy MA; Oluwole SF
Transplant Proc; 1993 Feb; 25(1 Pt 1):291. PubMed ID: 8438304
[No Abstract] [Full Text] [Related]
13. Nature of tolerance induction to peripheral (extrathymic) islet allografts.
Coulombe M; Lafferty KJ; Gill RG
Transplant Proc; 1994 Apr; 26(2):720-1. PubMed ID: 8171624
[No Abstract] [Full Text] [Related]
14. Cyclosporine treatment of BB rat pancreas transplant recipients: a functional and histologic analysis.
Bartlett ST; Dugoni WE
Transplant Proc; 1990 Apr; 22(2):736-8. PubMed ID: 2109393
[No Abstract] [Full Text] [Related]
15. Analysis of cytokine transcripts in pancreatic islet cell allografts during rejection and tolerance induction.
Nickerson P; Pacheco-Silva A; O'Connell PJ; Steurer W; Kelley VR; Strom TB
Transplant Proc; 1993 Feb; 25(1 Pt 2):984-5. PubMed ID: 8442291
[No Abstract] [Full Text] [Related]
16. Studies of host immunomodulation and prevention of pancreatic beta cell destruction.
Brayman KL; Naji A; Barker CF
Transplant Proc; 1990 Apr; 22(2):851-2. PubMed ID: 2109418
[No Abstract] [Full Text] [Related]
17. Prevention of autoimmune but not allogeneic destruction of grafted islets by different therapeutic strategies.
Kuttler B; Rösing K; Lehmann M; Brock J; Hahn HJ
J Mol Med (Berl); 1999 Jan; 77(1):226-9. PubMed ID: 9930969
[TBL] [Abstract][Full Text] [Related]
18. Prolongation of islet isograft survival in diabetic NOD mice by anti-L3T4 and anti-LYT2 monoclonal antibodies.
Matsuo S; Mullen Y; Wicker LS; Peterson LB; Nagata M; Tsunoda T; Clare-Salzler M
Transplant Proc; 1990 Apr; 22(2):880-1. PubMed ID: 2109427
[No Abstract] [Full Text] [Related]
19. Postoperative bone marrow infusions with cyclosporine, silica, and antilymphocyte serum in rat islet allografts.
Barneo L; Field MJ; Esteban MM
Transplant Proc; 1990 Apr; 22(2):859-60. PubMed ID: 2158178
[No Abstract] [Full Text] [Related]
20. Injection of bone marrow cells into the thymus to achieve tolerance in an islet xenotransplant (human-to-rat) model.
Dellagiacoma G; Rossi M; Castagna MT; Radin S; Vecchioni R
Transplant Proc; 1994 Jun; 26(3):1114-5. PubMed ID: 8029850
[No Abstract] [Full Text] [Related]
[Next] [New Search]
